 MALVERN, Pa., Sept. 29, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. Ocugen or the Company NASDAQ: OCGN, a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will participate in an in-person fireside chat at the Chardan 6 th Annual Genetic Medicines Conference being held October 3-4, 2022 in New York, NY. 